Literature DB >> 12777035

Experimental imaging of intracorneal ring segments with optical coherence tomography.

Christopher Wirbelauer1, Jörg Winkler, Christian Scholz, Heike Häberle, Duy Thoai Pham.   

Abstract

PURPOSE: To investigate the imaging of corneal structures with optical coherence tomography (OCT) after implantation of intracorneal ring segments (ICRS).
METHODS: In an experimental study with six porcine eyes, qualitative and quantitative imaging with corneal OCT using a wavelength of 1310 nm after implantation of ICRS was performed. The optical results were compared with light microscopy of the histological sections.
RESULTS: In corneal OCT, the ICRS revealed marked hyporeflective intrastromal areas, which correlated well with macroscopic and microscopic findings. Corneal OCT enabled precise images of the incision depth for the implantation of ICRS, and the exact intrastromal segment position.
CONCLUSIONS: Noncontact slit lamp-adapted corneal optical coherence tomography could be employed to clinically monitor corneal changes after implantation of ICRS, evaluate the depth of the segments to correlate refractive changes, and quantify the stromal wound healing response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777035     DOI: 10.3928/1081-597X-20030501-16

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  Optical coherence tomography for an in-vivo study of posterior-capsule-opacification types and their influence on the total-pulse energy required for Nd:YAG capsulotomy: a case series.

Authors:  Gregor Hawlina; Darko Perovšek; Brigita Drnovšek-Olup; Janez MoŽina; Peter Gregorčič
Journal:  BMC Ophthalmol       Date:  2014-11-18       Impact factor: 2.209

2.  Morphological characterization and clinical effects of stromal alterations after intracorneal ring segment implantation in keratoconus.

Authors:  Loïc Hamon; Ursula Schlötzer-Schrehardt; Fidelis A Flockerzi; Berthold Seitz; Loay Daas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-02       Impact factor: 3.535

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.